Telyrx Holdings Inc (TELY)

Currency in CAD
2.70
+0.15(+5.88%)
Closed·
TELY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.682.70
52 wk Range
2.004.25
Key Statistics
Prev. Close
2.55
Open
2.69
Day's Range
2.68-2.7
52 wk Range
2-4.25
Volume
1.3K
Average Volume (3m)
8.75K
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TELY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.00
Upside
+122.22%
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Telyrx Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.00
(+122.22% Upside)

Telyrx Holdings Inc Earnings Call Summary for Q1/2026

  • Q1 2026 revenue surged 180% YoY to $19.4M; fulfilled 236K prescriptions, up 188% from Q1 2025, driven by customer growth and operational scale.
  • Gross margin improved to 55% from 50% YoY; however, reported net loss of $4.7M and adjusted EBITDA loss of $2.3M versus prior year gain.
  • Stock declined 8.62% to $2.65 post-earnings, reflecting investor concerns over profitability despite strong revenue momentum and market expansion.
  • FY 2026 guidance: $112M revenue and $4M adjusted EBITDA expected, with progressive quarterly EBITDA improvement as operations scale throughout year.
  • CEO Slowey emphasized disciplined customer acquisition cost management and strong retention rates to support profitability targets amid competitive market.
Last Updated: 13/05/2026, 14:14
Read Full Transcript

Earnings

Latest Release
May 12, 2026
EPS / Forecast
-0.41 / --
Revenue / Forecast
19.39M / --
EPS Revisions
Last 90 days

TELY Income Statement

Compare TELY to Peers and Sector

Metrics to compare
TELY
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x10.0x
PEG Ratio
0.000.000.03
Price/Book
0.0x0.0x1.0x
Price / LTM Sales
0.0x0.0x3.0x
Upside (Analyst Target)
0.0%0.0%13.3%
Fair Value Upside
Unlock0.0%2.2%Unlock

TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
126.41K0.26%322.36K
Public Companies & Retail Investors
48.72M99.74%124.25M
Total
48.85M100.00%124.57M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Hyperion Capital Inc.0.26%126,414322

FAQ

What Is the Telyrx Holdings (TELY) Stock Price Today?

The Telyrx Holdings stock price today is 2.70 CAD.

What Stock Exchange Does Telyrx Holdings Trade On?

Telyrx Holdings is listed and trades on the Toronto Stock Exchange.

What Is the Stock Symbol for Telyrx Holdings?

The stock symbol for Telyrx Holdings is "TELY."

What Is the Telyrx Holdings Market Cap?

As of today, Telyrx Holdings market cap is 124.57M CAD.

What Is Telyrx Holdings's Earnings Per Share (TTM)?

The Telyrx Holdings EPS (TTM) is -0.93.

When Is the Next Telyrx Holdings Earnings Date?

Telyrx Holdings will release its next earnings report on Aug 10, 2026.

From a Technical Analysis Perspective, Is TELY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Telyrx Holdings Stock Split?

Telyrx Holdings has split 0 times.

What is the current trading status of Telyrx Holdings (TELY)?

As of Aug 08, 2026, Telyrx Holdings (TELY) is trading at a price of 2.70 CAD, with a previous close of 2.55 CAD. The stock has fluctuated within a day range of 2.68 CAD to 2.70 CAD, while its 52-week range spans from 2.00 CAD to 4.25 CAD.

What Is Telyrx Holdings (TELY) Price Target According to Analysts?

The average 12-month price target for Telyrx Holdings is 6.00 CAD, with a high estimate of 6 CAD and a low estimate of 6 CAD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +122.22% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.